Summit Therapeutics posts a wider Q4 loss as R&D spending surges. Its ivonescimab pipeline advances with a BLA filing and multiple late-stage cancer trials underway.
Summit Therapeutics Inc (SMMT) ends 2025 with a robust cash reserve and no debt, while advancing its clinical pipeline through strategic partnerships and increased R&D investments.
Summit Therapeutics Inc (NASDAQ:SMMT) shares are trading higher by 9.25% to $24.80 Thursday morning after the company announced it raised $235 million in net proceeds. What Happened: Summit ...
Summit Therapeutics (NASDAQ:SMMT) is one of the 17 biotechnology stocks with more than 50% upside. As of the close of play on ...
Hosted on MSN
Does Summit Therapeutics (SMMT) Have the Potential to Rally 44.6% as Wall Street Analysts Expect?
Summit Therapeutics PLC (SMMT) closed the last trading session at $25.85, gaining 10.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the most oversold NASDAQ stocks to invest in. On February 2, H.C. Wainwright reaffirmed a Buy rating on Summit Therapeutics Inc. (NASDAQ:SMMT) with a ...
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in ITT Inc (Symbol: ITT), where a total of 2,245 contracts have traded so far, representing ...
We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look at where Summit Therapeutics (NASDAQ:SMMT) stands against the other stocks ...
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in ADMA Biologics Inc (Symbol: ADMA), where a total of 26,278 contracts have traded so far, ...
Summit Therapeutics Inc. (NASDAQ:SMMT) on Friday noted that Akeso, Inc. announced the Chinese Health Authorities, the National Medical Products Administration (NMPA) approved ivonescimab for a second ...
We recently published 10 Stocks Exploding Higher: Bitcoin Miners Dominate the List. Summit Therapeutics Inc. (NASDAQ:SMMT) is one of Wednesday’s top performers. Summit Therapeutics surged by 16.05 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results